Moderna Inc. Stock Falls 5.8%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.

Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.

Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 26, 2026 16:33 ET (20:33 GMT)